Download PDF
Horm Metab Res 2004; 36(1): 73
DOI: 10.1055/s-2004-814356
Erratum
© Georg Thieme Verlag Stuttgart · New York

Expression of the Insulin-like Growth Factor-I Receptor in Primary Breast Cancer and Lymph Node Metastases: Correlations with Estrogen Receptors α and β

M.  Koda1 , S.  Sulkowski1 , C.  Garofalo2 , L.  Kanczuga-Koda1 , M.  Sulkowska1 , E.  Surmacz2
  • 1Department of Clinical Pathology, Medical University of Bialystok, Poland
  • 2Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, USA.
Further Information

Publication History

Publication Date:
03 May 2004 (online)

Also available at
   Permissions and Reprints

Correction to:

Expression of the Insulin-like Growth Factor-I Receptor in Primary Breast Cancer and Lymph Node Metastases: Correlations with Estrogen Receptors α and β Horm Metab Res 2003; 35(11/12): 794-801
DOI: 10.1055/s-2004-814152

This article in an erratum and refers to M. Koda et al. Expression of the Insulin-like Growth Factor-I Receptor in Primary Breast Cancer and Lymph Node Metastases: Correlations with Estrogen Receptors α and β in Hormone Metab Res, Issue 11/12, 2003; 35: 794 - 801 .

Figure [1] was printed in black and white but should have been printed in colours as shown below:

Fig. 1 Immunohistochemical demonstration of IGF-IR, ERα, and ERβ in breast cancer cells. IGF-IR, ERα, and ERβ were detected in primary and metastatic tumors. In addition, the expression and localization of ERα and ERβ was analyzed in MCF-7 cells. The analysis was performed as described in Materials and Methods. The original magnification for ERα staining in primary and metastatic tumors was 200 ×, in all other cases, the magnification was 400 ×.